Someone from my neurologist's office called this morning, to discuss my new MS drug prescription (Kesimpta). This was mostly things like, the next step is that I will hear from a specialty pharmacy, and what I should do if they are asking for a large copay. There are ways to get the drug company to cover all or most of that, but I'll have to ask, and I don't know how complicated the process is. The woman I spoke to said that the doctor's office doesn't know what my copay will be, because the insurance companies and pharmacies won't give them that information, they'll only tell the patient.
The drug will be shipped to my home, with ice packs to keep it cool, because it needs refrigeration. I'll be getting the first three doses (weeks 0, 1, and 2) at once, and then monthly doses, shipped one at a time. In this case they do mean monthly, rather than every four weeks, which may be easier to keep track of.
This afternoon, I filled out and submitted the "FinCEN" report about my Canadian bank account for 2023. I'd already collected the data, so this was a matter of doing a couple of calculations, then going to the appropriate website, and entering things like my name, address, and social security number, plus the information about the bank account (account number and maximum balance during the calendar year).
The drug will be shipped to my home, with ice packs to keep it cool, because it needs refrigeration. I'll be getting the first three doses (weeks 0, 1, and 2) at once, and then monthly doses, shipped one at a time. In this case they do mean monthly, rather than every four weeks, which may be easier to keep track of.
This afternoon, I filled out and submitted the "FinCEN" report about my Canadian bank account for 2023. I'd already collected the data, so this was a matter of doing a couple of calculations, then going to the appropriate website, and entering things like my name, address, and social security number, plus the information about the bank account (account number and maximum balance during the calendar year).
Tags: